In the liver, the activation of Nrf2 attenuates injuries of diverse etiologies, including chronic diseases such as NAFLD, by inducing heme oxygenase-1 (HO-1) expression and improving GSH efficacy [116,117]. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatotic liver disease.